COLO-RECTAL CANCER (DMMR/MSI-H CRC)
Clinical trials for COLO-RECTAL CANCER (DMMR/MSI-H CRC) explained in plain language.
Never miss a new study
Get alerted when new COLO-RECTAL CANCER (DMMR/MSI-H CRC) trials appear
Sign up with your email to follow new studies for COLO-RECTAL CANCER (DMMR/MSI-H CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: immune drug before surgery for tough colorectal cancer
Disease control Recruiting nowThis study looks at whether giving the drug tislelizumab before surgery can help people with a certain type of colorectal cancer (dMMR/MSI-H). About 30 adults with stage II or III cancer will get three doses of the drug, then have surgery. Researchers will check if the cancer dis…
Matched conditions: COLO-RECTAL CANCER (DMMR/MSI-H CRC)
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
Cancer patients choose: quick shot or long IV drip?
Knowledge-focused Recruiting nowThis study asks people with certain cancers whether they prefer getting their immunotherapy (nivolumab or pembrolizumab) as a quick shot under the skin or as a longer IV infusion. About 880 participants will try both methods and share their preference. The goal is to understand w…
Matched conditions: COLO-RECTAL CANCER (DMMR/MSI-H CRC)
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC